SuperworthVolitionrx VNRX
- Market cap
- $2.4M
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 1.0×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $2.5M
- +86% on a year ago
- Net margin
- n/m
- outside −100% to 100%
- Free cash flow yield
- −824.1%
Volitionrx trades at 1.0× sales. Its trailing earnings are negative, so it has no PE. Revenue was $2.5M over the last twelve months, up 86% on a year earlier.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $165.2K+405% | $244K+104% | $171.5K+15% | $395.8K+83% | $474.5K+187% | $191.7K−21% | $246.4K+44% | $406.7K+3% | $627.3K+32% | $447K+133% | $985.1K+300% | $398.7K−2% | |
| R&D | $4.7M+16% | $4.5M+10% | $4.6M−6% | $3.7M−32% | $3.5M−25% | $2.6M−43% | $2.6M−44% | $2.7M−27% | $2.3M−34% | $2.5M−5% | $2.9M+9% | $1.8M−34% |
| SG&A | $4.2M+4% | $4.4M+11% | $3.9M−9% | $3.7M−15% | $2.9M−31% | $3.4M−24% | $3.2M−20% | $4M+9% | $3.4M+20% | $2.8M−17% | $3.5M+10% | $2.8M−31% |
| −$8.7M+8% | −$8.7M+9% | −$8.4M−7% | −$7M−27% | −$5.9M−32% | −$5.8M−34% | −$5.5M−34% | −$6.3M−10% | −$5.1M−13% | −$4.8M−17% | −$5.3M−3% | −$4.2M−34% | |
| Interest expense | n/a | n/a | n/a | n/a | n/a | n/a | $96.7K | $123.4K | n/a | n/a | $125.8K+30% | $740.4K+500% |
| n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
| Net income | −$8.4M+7% | −$9.1M+23% | −$8.4M−7% | −$7M−28% | −$5.8M−31% | −$5.8M−36% | −$5.4M−35% | −$6.3M−10% | −$5.4M−8% | −$6.3M+8% | −$6.7M+23% | −$7.3M+17% |
| n/a | n/a | −$2.00−33% | −$1.60−43% | −$1.40 | −$1.20 | −$1.12−44% | −$1.22−24% | −$1.00−29% | −$1.00−17% | −$0.97−13% | −$0.85−30% | |
| n/a | n/a | 4.1M+36% | 4.1M+24% | 4.4M | 4.7M | 4.8M+18% | 5.1M+24% | 5.4M+23% | 6M+29% | 6.9M+43% | 9.2M+78% |
EPS, diluted: 17 periods, Q4 FY11 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 11 periods, Q4 FY11 to Q4 FY21: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY24 and Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Healthcare nearest Volitionrx's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| VNRXVolitionrx | $2.4M | n/m | n/a | 1.0× | +86% | n/m | |
| OXBROXBRIDGE RE HOLDINGS | $7.7M | 47.5× | 9.6× | 2.8× | +40% | 4.7% | |
| EDUCEducational Development | $8.7M | 5.4× | 11.3× | 0.4× | −32% | 8.6% | |
| GTIMGood Times Restaurants | $13.6M | 6.1× | 13.6× | 0.1× | −6% | 1.7% | |
| MDRRMedalist Diversified | $15.4M | 2.5× | 3.0× | 1.6× | −1% | 80.2% | |
| BCGBinah Capital | $18.2M | 6.7× | 20.8× | 0.1× | +8% | 2.2% | |
| VIPVulcan Infrastructure & Power | $19.6M | 17.9× | 24.4× | 0.4× | −14% | 1.0% | |
| MXCMexco Energy | $20.5M | 13.4× | 13.3× | 3.0× | −9% | 23.3% | |
| CKXCKX Lands | $21.5M | 7.4× | 32.6× | 31.0× | −17% | n/m | |
| MSGMMotorsport Games | $22.5M | 11.4× | 11.5× | 1.5× | +79% | 16.2% | |
| Peer median | $18.2M | 7.4× | 13.3× | 1.5× | −6% | 6.7% |
More on Volitionrx
Each number over time
Where it ranks
Its groups
About
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .